Biblio

Export 232 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is M  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
M. Marjańska, J McCarten, R., Hodges, J. S., Hemmy, L. S., and Terpstra, M., “Distinctive Neurochemistry in Alzheimer's Disease via 7 T In Vivo Magnetic Resonance Spectroscopy.”, J Alzheimers Dis, vol. 68, no. 2, pp. 559-569, 2019.
M. Marizzoni, Cattaneo, A., Mirabelli, P., Festari, C., Lopizzo, N., Nicolosi, V., Mombelli, E., Mazzelli, M., Luongo, D., Naviglio, D., Coppola, L., Salvatore, M., and Frisoni, G. B., “Short-Chain Fatty Acids and Lipopolysaccharide as Mediators Between Gut Dysbiosis and Amyloid Pathology in Alzheimer's Disease.”, J Alzheimers Dis, vol. 78, no. 2, pp. 683-697, 2020.
M. Marizzoni, Ferrari, C., Jovicich, J., Albani, D., Babiloni, C., Cavaliere, L., Didic, M., Forloni, G., Galluzzi, S., Hoffmann, K. - T., Molinuevo, J. Luis, Nobili, F., Parnetti, L., Payoux, P., Ribaldi, F., Rossini, P. Maria, Schönknecht, P., Soricelli, A., Hensch, T., Tsolaki, M., Visser, P. Jelle, Wiltfang, J., Richardson, J. C., Bordet, R., Blin, O., and Frisoni, G. B., “Predicting and Tracking Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease: Structural Brain Biomarkers.”, J Alzheimers Dis, 2018.
R. E. Marioni, Campbell, A., Hagenaars, S. P., Nagy, R., Amador, C., Hayward, C., Porteous, D. J., Visscher, P. M., and Deary, I. J., “Genetic Stratification to Identify Risk Groups for Alzheimer's Disease.”, J Alzheimers Dis, vol. 57, no. 1, pp. 275-283, 2017.
J. Marín-Muñoz, Noguera-Perea, M. Fuensanta, Gómez-Tortosa, E., López-Motos, D., Antequera-Torres, M., Martínez-Herrada, B., Manzanares-Sánchez, S., Vivancos-Moreau, L., Legaz-García, A., Del Arroyo, A. Rábano- Gu, and Antúnez-Almagro, C., “Novel Mutation (Gly212Val) in the PS2 Gene Associated with Early-Onset Familial Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 1, pp. 73-8, 2016.
E. Mariani, Chattat, R., Vernooij-Dassen, M., Koopmans, R., and Engels, Y., “Care Plan Improvement in Nursing Homes: An Integrative Review.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1621-1638, 2017.
E. Mariani, Chattat, R., Ottoboni, G., Koopmans, R., Vernooij-Dassen, M., and Engels, Y., “The Impact of a Shared Decision-Making Training Program on Dementia Care Planning in Long-Term Care.”, J Alzheimers Dis, vol. 64, no. 4, pp. 1123-1135, 2018.
P. Maresova, Dolejš, J., and Kuca, K., “Call for a Uniform Strategy of Collecting Alzheimer's Disease Costs: A Review and Meta-Analysis.”, J Alzheimers Dis, vol. 63, no. 1, pp. 227-238, 2018.
P. Maresova, Klimova, B., Novotny, M., and Kuca, K., “Alzheimer's and Parkinson's Diseases: Expected Economic Impact on Europe-A Call for a Uniform European Strategy.”, J Alzheimers Dis, vol. 54, no. 3, pp. 1123-1133, 2016.
S. Marcolini, Rojczyk, P., Seitz-Holland, J., Koerte, I. K., Alosco, M. L., and Bouix, S., “Posttraumatic Stress and Traumatic Brain Injury: Cognition, Behavior, and Neuroimaging Markers in Vietnam Veterans.”, J Alzheimers Dis, vol. 95, no. 4, pp. 1427-1448, 2023.
N. Marchesi, Amadio, M., Colombrita, C., Govoni, S., Ratti, A., and Pascale, A., “PKC Activation Counteracts ADAM10 Deficit in HuD-Silenced Neuroblastoma Cells.”, J Alzheimers Dis, vol. 54, no. 2, pp. 535-47, 2016.
M. Marano, Pompucci, A., Motolese, F., Rossi, M., Coletta, E., Di Lazzaro, V., Fasano, A., and Petrella, G., “Normal Pressure Hydrocephalus in Down Syndrome: The Report of Two Cases.”, J Alzheimers Dis, vol. 77, no. 3, pp. 979-984, 2020.
M. Mapstone, Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., Nazar, M. D., Rich, S. A., Berlau, D. J., Peltz, C. B., Tan, M. T., Kawas, C. H., and Federoff, H. J., “Plasma phospholipids identify antecedent memory impairment in older adults.”, Nat Med, vol. 20, no. 4, pp. 415-8, 2014.
P. R. Manzine, Pelucchi, S., Horst, M. A., Vale, F. A. C., Pavarini, S. C. I., Audano, M., Mitro, N., Di Luca, M., Marcello, E., and Cominetti, M. R., “microRNA 221 Targets ADAM10 mRNA and is Downregulated in Alzheimer's Disease.”, J Alzheimers Dis, vol. 61, no. 1, pp. 113-123, 2018.
Y. Manso, Comes, G., López-Ramos, J. C., Belfiore, M., Molinero, A., Giralt, M., Carrasco, J., Adlard, P. A., Bush, A. I., Delgado-García, J. María, and Hidalgo, J., “Overexpression of Metallothionein-1 Modulates the Phenotype of the Tg2576 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 51, no. 1, pp. 81-95, 2016.
A. Manousopoulou, Saito, S., Yamamoto, Y., Al-Daghri, N. M., Ihara, M., Carare, R. O., and Garbis, S. D., “Hemisphere Asymmetry of Response to Pharmacologic Treatment in an Alzheimer's Disease Mouse Model.”, J Alzheimers Dis, vol. 51, no. 2, pp. 333-8, 2016.
J. E. Manousakis, Scovelle, A. J., Rajaratnam, S. M. W., Naismith, S. L., and Anderson, C., “Advanced Circadian Timing and Sleep Fragmentation Differentially Impact on Memory Complaint Subtype in Subjective Cognitive Decline.”, J Alzheimers Dis, vol. 66, no. 2, pp. 565-577, 2018.
G. D. Manocha, Ghatak, A., Puig, K. L., Kraner, S. D., Norris, C. M., and Combs, C. K., “NFATc2 Modulates Microglial Activation in the AβPP/PS1 Mouse Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 58, no. 3, pp. 775-787, 2017.
M. Mandecka, Budziszewska, M., Barczak, A., Pepłońska, B., Chodakowska-Żebrowska, M., Filipek-Gliszczyńska, A., Nesteruk, M., Styczyńska, M., Barcikowska, M., and Gabryelewicz, T., “Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 157-68, 2016.
P. K. Mandal, Shukla, D., Govind, V., Boulard, Y., and Ersland, L., “Glutathione Conformations and Its Implications for in vivo Magnetic Resonance Spectroscopy.”, J Alzheimers Dis, vol. 59, no. 2, pp. 537-541, 2017.
G. Manassero, Guglielmotto, M., Monteleone, D., Vasciaveo, V., Butenko, O., Tamagno, E., Arancio, O., and Tabaton, M., “Dual Mechanism of Toxicity for Extracellular Injection of Tau Oligomers versus Monomers in Human Tau Mice.”, J Alzheimers Dis, vol. 59, no. 2, pp. 743-751, 2017.
C. B. Malpas, Saling, M. M., Velakoulis, D., Desmond, P., Hicks, R. J., Zetterberg, H., Blennow, K., and O'Brien, T. J., “Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type.”, J Alzheimers Dis, vol. 62, no. 1, pp. 417-427, 2018.
C. B. Malpas, Saling, M. M., Velakoulis, D., Desmond, P., and O'Brien, T. J., “Tau and Amyloid-β Cerebrospinal Fluid Biomarkers have Differential Relationships with Cognition in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 47, no. 4, pp. 965-75, 2015.
C. B. Malpas, Vivash, L., Genc, S., Saling, M. M., Desmond, P., Steward, C., Hicks, R. J., Callahan, J., Brodtmann, A., Collins, S., Macfarlane, S., Corcoran, N. M., Hovens, C. M., Velakoulis, D., and O'Brien, T. J., “A Phase IIa Randomized Control Trial of VEL015 (Sodium Selenate) in Mild-Moderate Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 1, pp. 223-32, 2016.
J. Malone, Jung, J., Tran, L., and Zhao, C., “Periodontal Disease and Risk of Dementia in Medicare Patients with Hepatitis C Virus.”, J Alzheimers Dis, vol. 85, no. 3, pp. 1301-1308, 2021.

Pages